RPG Life Sciences launches Naprosyn ES in India
RPG Life Sciences launches Naprosyn ES in India. The company has introduced Naprosyn ES, an enhanced-release formulation of naproxen, targeting chronic pain conditions. This launch expands its presence in the anti-inflammatory segment. The product is expected to contribute to revenue growth in the coming quarters.
📊 STOCKS: RPGLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #ProductLaunch
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.